Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
European Journal of Endocrinology|January 30, 2009
Unique expression pattern of the EMT markers Snail, Twist and E-cadherin in benign and malignant parathyroid neoplasiaVolker Fendrich, Jens Waldmann, Georg Feldmann, et al.
World Journal of Surgery|March 10, 2016
Minimally Invasive Versus Open Pancreatic Surgery in Patients with Multiple Endocrine Neoplasia Type 1Caroline L Lopez, Max B Albers, Carmen Bollmann, et al.
The Journal of Surgical Research|February 14, 2018
Expression of neuropeptide Y and its receptors Y1 and Y2 in pancreatic intraepithelial neoplasia and invasive pancreatic cancer in a transgenic mouse model and human samples of pancreatic cancerJens Waldmann, Volker Fendrich, Martin Reichert, et al.
Neoplasia (New York, N.Y.)|June 24, 2014
Chronic pancreatitis and systemic inflammatory response syndrome prevent impact of chemotherapy with gemcitabine in a genetically engineered mouse model of pancreatic cancerRichard F Knoop, Moritz Sparn, Jens Waldmann, et al.
Annals of Surgery|January 18, 2011
Hedgehog inhibition with cyclopamine represses tumor growth and prolongs survival in a transgenic mouse model of islet cell tumorsVolker Fendrich, Johannes Rehm, Jens Waldmann, et al.
Cancers|November 12, 2013
Epithelial-mesenchymal transition is a critical step in tumorgenesis of pancreatic neuroendocrine tumorsVolker Fendrich, Katja Maschuw, Jens Waldmann, et al.
Endocrine|April 29, 2009
Mutations and polymorphisms in the SDHB, SDHD, VHL, and RET genes in sporadic and familial pheochromocytomasJens Waldmann, Peter Langer, Nils Habbe, et al.
Langenbeck'S Archives of Surgery|August 31, 2013
Aspirin prolongs survival and reduces the number of Foxp3+ regulatory T cells in a genetically engineered mouse model of pancreatic cancerLars Plassmeier, Richard Knoop, Jens Waldmann, et al.
World Journal of Surgery|April 8, 2009
Screening of patients with multiple endocrine neoplasia type 1 (MEN-1): a critical analysis of its valueJens Waldmann, Volker Fendrich, Nils Habbe, et al.
Thescientificworldjournal|January 25, 2013
Sorafenib inhibits tumor growth and improves survival in a transgenic mouse model of pancreatic islet cell tumorsVolker Fendrich, Katja Maschuw, Johannes Rehm, et al.
Pageof 6